Search

everythinglearnresearchcommunity

for

Search:↓

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

New research suggests treating hair loss should focus on common inflammation rather than individual molecules.

New acne treatments show promise as alternatives to traditional therapies.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

New findings suggest the protein linked to Birt–Hogg–Dubé syndrome is important in cell signaling and could affect treatment understanding.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Increased PPARGC1α relates to hair thinning in common baldness.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Gene differences found in hair follicles linked to male baldness.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Certain proteins are significantly increased in the skin of people with hidradenitis suppurativa.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

PRP shows promise for treating hair loss but needs more research.

Biotin and acetazolamide improved hair and nail growth, mental function, and reduced headaches in a child with autism.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Hair loss in androgenic alopecia patients is linked to changes in certain genes that control cell growth and death.

The research found that certain genes are linked to male pattern baldness, but these same genes do not affect female pattern hair loss.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.